Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fleishman

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Signal Transduction and Targeted Therapy|December 10, 2023
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseasesYumin Wang, Jing Hu, Shuang Wu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 31, 2024
Research progress on gene mutations and drug resistance in leukemiaXiangyu Ma, Jiamin Xu, Yanan Wang, et al.
Annals of the New York Academy of Sciences|December 14, 2004
L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysisR A Cruciani, E Dvorkin, P Homel, et al.
Psycho-Oncology|February 11, 2000
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partnersJ M Donnelly, A B Kornblith, S Fleishman, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 13, 2025
Overcoming cancer therapy resistance: From drug innovation to therapeuticsJin-Rui Wei, Meng-Yi Lu, Tian-Hua Wei, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Bioorganic Chemistry|September 13, 2025
Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitorsAbosede Salami, Ugochi Adiele, Griffin Coate, et al.
Psycho-Oncology|April 18, 2000
Involving family members in cancer care: focus group considerations of patients and oncological providersJ Speice, J Harkness, H Laneri, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Signal Transduction and Targeted Therapy|December 10, 2023
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseasesYumin Wang, Jing Hu, Shuang Wu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 31, 2024
Research progress on gene mutations and drug resistance in leukemiaXiangyu Ma, Jiamin Xu, Yanan Wang, et al.
Annals of the New York Academy of Sciences|December 14, 2004
L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysisR A Cruciani, E Dvorkin, P Homel, et al.
Psycho-Oncology|February 11, 2000
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partnersJ M Donnelly, A B Kornblith, S Fleishman, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 13, 2025
Overcoming cancer therapy resistance: From drug innovation to therapeuticsJin-Rui Wei, Meng-Yi Lu, Tian-Hua Wei, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Bioorganic Chemistry|September 13, 2025
Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitorsAbosede Salami, Ugochi Adiele, Griffin Coate, et al.
Psycho-Oncology|April 18, 2000
Involving family members in cancer care: focus group considerations of patients and oncological providersJ Speice, J Harkness, H Laneri, et al.
Pageof 5